Glycimet-PG1 Tablet ER
Marketer
Scott Edil Pharmacia Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glycimet-PG1 Tablet ER
Extended-release Glycimet-PG1 tablets are a dual-action medication managing blood glucose. Used alongside diet and exercise, they enhance glycemic control in adult type 2 diabetics by optimizing insulin utilization and reducing blood sugar. Dosage and frequency should strictly adhere to your physician's instructions; administer with food to prevent gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose risks hypoglycemia. Concomitant use with other antidiabetics, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Consult your physician before use during pregnancy or breastfeeding. Renal function will be assessed before prescription. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Glycimet-PG1 Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Glycimet-PG1 Tablet ER
Managing type 2 diabetes
Major Benefits of Glycimet-PG1 Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycimet-PG1 Extended Release tablets should be administered with a meal.
Common Side effects of Glycimet-PG1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glycimet-PG1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycimet-PG1 Extended-Release Tablets should be taken with meals.
How Glycimet-PG1 Tablet ER works:
Glycimet-PG1 ER tablets contain a triple-action formulation of glimepiride, metformin, and pioglitazone to manage blood sugar. These medications employ distinct mechanisms to enhance glycemic control when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glycimet-PG1 Tablet ER and alcohol poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glycimet-PG1 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glycimet-PG1 tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glycimet-PG1 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Consult your physician.
LiverCAUTION
Patients with liver impairment should use Glycimet-PG1 Extended-Release tablets cautiously, potentially requiring dosage modification under medical supervision. Glycimet-PG1 ER is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glycimet-PG1 Tablet ER :
Should you forget to take a Glycimet-PG1 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glycimet-PG1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently